Outcomes of at-risk participants’ referral (n=37)
| N | (%) | |
| Participants completed uptake of referral follow-up | 37 | (52.1) |
| Participants visited a doctor to discuss pharmacist-delivered screening results | 9 | (24.3) |
| Visited doctor straight away | 6 | (16.2) |
| Made some changes and went to doctor later | 1 | (2.7) |
| Discussed results at routine visit | 2 | (5.4) |
| Participants who did not visit a doctor | 28 | (75.6) |
| Have not visited doctor yet but intend to | 11 | (29.7) |
| Did not think it was necessary | 1 | (2.7) |
| Have not visited doctor yet and made no plans | 16 | (43.2) |
| Physician knew about pharmacy screening | 5 | (55.5) |
| Referral letter given to the doctor | 2 | (40.0) |
| Told doctor about pharmacy screening | 3 | (60.0) |
| Doctor treated the results of pharmacy screening seriously | 4 | (80.0) |
| Follow-up tests were undertaken by the physician | 7 | (77.7) |
| Blood pressure | 3 | (42.8) |
| Total cholesterol | 4 | (57.1) |
| HDL cholesterol | 3 | (42.8) |
| Blood sugar level | 4 | (57.1) |
| Waist | 1 | (14.2) |
| Weight | 2 | (28.5) |
| Other | 4 | (44.4) |
| Lifestyle changes since screening | ||
| Increased regular exercise | 7 | (36.8) |
| Attempted to lose weight | 11 | (57.8) |
| Improved diet | 12 | (63.1) |
| Started new medications | 4 | (40.0) |
HDL, high-density lipoprotein.